53. Sjogren syndrome Clinical trials / Disease details
Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02503189 (ClinicalTrials.gov) | November 23, 2016 | 17/7/2015 | A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome | Dry Eye With Sjögren's Syndrome | Drug: KCT-0809 ophthalmic solution;Drug: Placebo | Kissei Pharmaceutical Co., Ltd. | NULL | Completed | 20 Years | N/A | All | Phase 3 | Japan | ||
| 2 | NCT02503163 (ClinicalTrials.gov) | November 23, 2016 | 17/7/2015 | A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome | Dry Eye With Sjögren's Syndrome | Drug: KCT-0809 ophthalmic solution | Kissei Pharmaceutical Co., Ltd. | NULL | Completed | 20 Years | N/A | All | Phase 3 | Japan | ||
| 3 | NCT02503176 (ClinicalTrials.gov) | August 2015 | 17/7/2015 | An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome | Dry Eye With Sjögren's Syndrome | Drug: KCT-0809 ophthalmic solution | Kissei Pharmaceutical Co., Ltd. | NULL | Terminated | 20 Years | N/A | All | Phase 3 | Japan |